Shire Takes Aim At Mylan Again In New Intuniv Patent Suit

By Ben James (December 15, 2011, 6:03 PM EST) -- Shire LLC slapped Mylan Inc. with another patent suit over the attention deficit hyperactivity disorder drug Intuniv in West Virginia federal court Thursday, after Mylan changed its bid for regulatory approval of generic Intuniv to include three more dosage strengths....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!